Paul D. Kassner

3.4k total citations · 1 hit paper
46 papers, 2.6k citations indexed

About

Paul D. Kassner is a scholar working on Molecular Biology, Immunology and Allergy and Immunology. According to data from OpenAlex, Paul D. Kassner has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Immunology and Allergy and 11 papers in Immunology. Recurrent topics in Paul D. Kassner's work include Cell Adhesion Molecules Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and RNA Interference and Gene Delivery (5 papers). Paul D. Kassner is often cited by papers focused on Cell Adhesion Molecules Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and RNA Interference and Gene Delivery (5 papers). Paul D. Kassner collaborates with scholars based in United States, South Korea and Canada. Paul D. Kassner's co-authors include Martin E. Hemler, Timothy A. Springer, R. Alon, Bosco M. C. Chan, Erik B. Finger, James A. Schiro, Thomas S. Kupper, H. Randolph Byers, William T. Roswit and Arthur Z. Eisen and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Neuron.

In The Last Decade

Paul D. Kassner

45 papers receiving 2.5k citations

Hit Papers

The integrin VLA-4 supports tethering and rolling in flow... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers

Paul D. Kassner
Nelly Kieffer Luxembourg
Chungho Kim South Korea
Shouchun Liu United States
Scott D. Blystone United States
Christopher S. Stipp United States
Martin Pfaff Germany
Bronislawa Petryniak United States
Paul D. Kassner
Citations per year, relative to Paul D. Kassner Paul D. Kassner (= 1×) peers Miguel R. Campanero

Countries citing papers authored by Paul D. Kassner

Since Specialization
Citations

This map shows the geographic impact of Paul D. Kassner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Kassner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Kassner more than expected).

Fields of papers citing papers by Paul D. Kassner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Kassner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Kassner. The network helps show where Paul D. Kassner may publish in the future.

Co-authorship network of co-authors of Paul D. Kassner

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Kassner. A scholar is included among the top collaborators of Paul D. Kassner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Kassner. Paul D. Kassner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Tae Min, Nuttapong Ngamphaiboon, Ki Hyeong Lee, et al.. (2023). 629-C Phase 2 safety and efficacy of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with non-small cell lung cancer not previously treated with checkpoint inhibitor. SHILAP Revista de lepidopterología. A1808–A1808. 1 indexed citations
2.
Bissonnette, Robert, Janet DuBois, Paola Facheris, et al.. (2023). Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study. Allergy. 79(4). 924–936. 17 indexed citations
3.
Adamik, Juraj, Rakesh K. Goyal, William W. Ho, et al.. (2023). 704 Biological activity of FLX475, an oral CCR4 antagonist, as monotherapy and in combination with pembrolizumab in advanced cancer. SHILAP Revista de lepidopterología. A799–A799. 1 indexed citations
4.
Jorapur, Aparna, Lisa A. Marshall, Mengshu Xu, et al.. (2022). EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22. PLoS Pathogens. 18(1). e1010200–e1010200. 19 indexed citations
5.
Guttman‐Yassky, Emma, Ana B. Pavel, Paola Facheris, et al.. (2022). 822 RPT193, a CCR4 inhibitor, improves the inflammatory skin transcriptomic profile in patients with atopic dermatitis. Journal of Investigative Dermatology. 142(8). S143–S143. 1 indexed citations
6.
Hale, Christopher M., Qingwen Cheng, Ming Huang, et al.. (2016). Identification of modulators of autophagic flux in an image-based high content siRNA screen. Autophagy. 12(4). 713–726. 49 indexed citations
7.
Baribault, Hélène, Hongfei Ge, Jinghong Wang, et al.. (2014). Advancing therapeutic discovery through phenotypic screening of the extracellular proteome using hydrodynamic intravascular injection. Expert Opinion on Therapeutic Targets. 18(11). 1253–1264. 2 indexed citations
8.
Nolan-Stevaux, Olivier, Donato Tedesco, Seamus P. Ragan, et al.. (2013). Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment. PLoS ONE. 8(6). e67316–e67316. 23 indexed citations
9.
Wang, Xiangyun, et al.. (2010). Use of Cryopreserved Cell Aliquots in the High-Throughput Screening of Small Interfering RNA Libraries. SLAS DISCOVERY. 15(5). 469–477. 3 indexed citations
10.
Quon, Kim & Paul D. Kassner. (2009). RNA interference screening for the discovery of oncology targets. Expert Opinion on Therapeutic Targets. 13(9). 1027–1035. 17 indexed citations
11.
Cutler, Gene & Paul D. Kassner. (2008). Copy number variation in the mouse genome: implications for the mouse as a model organism for human disease. Cytogenetic and Genome Research. 123(1-4). 297–306. 14 indexed citations
12.
Kassner, Paul D., Michael A. Burg, Andrew Baird, & David LaRocca. (1999). Genetic Selection of Phage Engineered for Receptor-Mediated Gene Transfer to Mammalian Cells. Biochemical and Biophysical Research Communications. 264(3). 921–928. 64 indexed citations
13.
Kassner, Paul D., William G. Conroy, & Darwin K. Berg. (1998). Organizing Effects of Rapsyn on Neuronal Nicotinic Acetylcholine Receptors. Molecular and Cellular Neuroscience. 10(5-6). 258–270. 15 indexed citations
14.
Kassner, Paul D. & Darwin K. Berg. (1997). Differences in the fate of neuronal acetylcholine receptor protein expressed in neurons and stably transfected cells. Journal of Neurobiology. 33(7). 968–982. 45 indexed citations
15.
Collins, Tassie L., et al.. (1994). Adhesion receptors in lymphocyte activation. Current Opinion in Immunology. 6(3). 385–393. 75 indexed citations
16.
Kassner, Paul D. & Martin E. Hemler. (1993). Interchangeable alpha chain cytoplasmic domains play a positive role in control of cell adhesion mediated by VLA-4, a beta 1 integrin.. The Journal of Experimental Medicine. 178(2). 649–660. 88 indexed citations
17.
Campanero, Miguel R., Alicia G. Arroyo, Rafael Pulido, et al.. (1992). Functional role of α2/β1 and α4/β1 integrins in leukocyte intercellular adhesion induced through the common β1 subunit. European Journal of Immunology. 22(12). 3111–3119. 61 indexed citations
18.
Kassner, Paul D., Joaquı́n Teixidó, Bosco M. C. Chan, Christina M. Parker, & Martin E. Hemler. (1992). Analyses of VLA-4 Structure and Function. Advances in experimental medicine and biology. 323. 163–170. 8 indexed citations
19.
Chan, Bosco M. C., Paul D. Kassner, James A. Schiro, et al.. (1992). Distinct cellular functions mediated by different VLA integrin α subunit cytoplasmic domains. Cell. 68(6). 1051–1060. 272 indexed citations
20.
Schiro, James A., Bosco M. C. Chan, William T. Roswit, et al.. (1991). Integrin α2β1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell. 67(2). 403–410. 328 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026